161 related articles for article (PubMed ID: 26562400)
21. Decreased circulating iNKT cell numbers in refractory coeliac disease.
Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
[TBL] [Abstract][Full Text] [Related]
22. Azathioprine and prednisone combination therapy in refractory coeliac disease.
Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
[TBL] [Abstract][Full Text] [Related]
23. Refractory celiac disease: from bench to bedside.
Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
[TBL] [Abstract][Full Text] [Related]
24. Refractory celiac disease.
Malamut G; Cellier C
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):323-8. PubMed ID: 24502536
[TBL] [Abstract][Full Text] [Related]
25. Investigation of molecular markers in the diagnosis of refractory coeliac disease in a large patient cohort.
O'Shea U; Abuzakouk M; O'Morain C; O'Donoghue D; Sheahan K; Watson P; O'Briain S; Alexander D; Catherwood M; Jackson J; Kelly J; Feighery C
J Clin Pathol; 2008 Nov; 61(11):1200-2. PubMed ID: 18955575
[TBL] [Abstract][Full Text] [Related]
26. The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
García-Hoz C; Crespo L; Lopez N; De Andrés A; Ríos León R; Santón A; Garriga M; Butz E; León F; Roy Ariño G
Dig Dis; 2020; 38(6):490-499. PubMed ID: 32015237
[TBL] [Abstract][Full Text] [Related]
27. Refractory celiac disease.
Abdallah H; Leffler D; Dennis M; Kelly CP
Curr Gastroenterol Rep; 2007 Oct; 9(5):401-5. PubMed ID: 17991341
[TBL] [Abstract][Full Text] [Related]
28. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
[TBL] [Abstract][Full Text] [Related]
29. Clinical staging and survival in refractory celiac disease: a single center experience.
Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
[TBL] [Abstract][Full Text] [Related]
30. The management of refractory coeliac disease.
Woodward J
Ther Adv Chronic Dis; 2013 Mar; 4(2):77-90. PubMed ID: 23556127
[TBL] [Abstract][Full Text] [Related]
31. Refractory celiac disease.
Rishi AR; Rubio-Tapia A; Murray JA
Expert Rev Gastroenterol Hepatol; 2016; 10(4):537-46. PubMed ID: 26603931
[TBL] [Abstract][Full Text] [Related]
32. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Tjon JM; Kooy-Winkelaar YM; Tack GJ; Mommaas AM; Schreurs MW; Schilham MW; Mulder CJ; van Bergen J; Koning F
J Immunol; 2011 Jun; 186(11):6304-12. PubMed ID: 21525383
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms and management of refractory coeliac disease.
van Gils T; Nijeboer P; van Wanrooij RL; Bouma G; Mulder CJ
Nat Rev Gastroenterol Hepatol; 2015 Oct; 12(10):572-9. PubMed ID: 26347156
[TBL] [Abstract][Full Text] [Related]
34. Budesonide Induces Favourable Histologic and Symptomatic Recovery in Patients with Non-responsive and Refractory Coeliac Disease When Given in an Open Capsule Format.
Saitta D; Henneken LM; Apputhurai P; Chen Yi Mei SL; Tye-Din JA
Dig Dis Sci; 2024 Apr; ():. PubMed ID: 38683433
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Schmitz F; Tjon JM; van Bergen J; Koning F
Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
[TBL] [Abstract][Full Text] [Related]
36. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.
Verbeek WH; von Blomberg BM; Scholten PE; Kuik DJ; Mulder CJ; Schreurs MW
Am J Gastroenterol; 2008 Dec; 103(12):3152-8. PubMed ID: 19086962
[TBL] [Abstract][Full Text] [Related]
37. Refractory celiac disease: epidemiology and clinical manifestations.
Malamut G; Cellier C
Dig Dis; 2015; 33(2):221-226. PubMed ID: 25925926
[TBL] [Abstract][Full Text] [Related]
38. Refractory Celiac Disease.
Malamut G; Cellier C
Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
[TBL] [Abstract][Full Text] [Related]
39. A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease.
Mulder CJ; Wahab PJ; Meijer JW; Metselaar E
Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1183-8. PubMed ID: 11711774
[TBL] [Abstract][Full Text] [Related]
40. Cavitating mesenteric lymph node syndrome: a rare complication of refractory celiac disease.
Sanson E; Gassler N; Trautwein C; Wasmuth HE
Z Gastroenterol; 2010 Sep; 48(9):1133-7. PubMed ID: 20839163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
